Answers are grounded in this paper and cite their sources.
The need for a concentrated blood product useful for mobile combat units in World War II fostered fractionation and investigations of albumin use by an alliance of the American Red Cross, academic institutions, and federal governmental agencies. Early studies in the mid-1940s included evaluation of iso-oncotic (5%) and hyperoncotic (25%) albumin preparations for different indications. It was recognized that product formulation, dosing regimen, and comorbidities could influence efficacy and safety. For example, the sodium content ranged from 100 to 160 mmol/L.1 Sodium is largely responsible for the osmolarity of albumin solutions because osmolarity is a function of the number, not size, of particles. The importance of selecting the appropriate albumin formulation based on indication was clear from the labeling of hyperoncotic albumin at the time, which stated, “Precaution: In the presence of dehydration, albumin must be given with or followed by additional fluids.”2 Contemporary uses of albumin include volume expansion, as well as replacement in some settings. Improper administration has been associated with pulmonary edema, cerebral edema, and financial toxicity.3 The purpose of this paper is to provide an overview of key research of albumin administration in the critical care setting, beginning with a historical perspective of early guidelines and systematic reviews, followed by a discussion of the methodological limitations present in many of the evaluations that make up current clinical practice guidelines. Studies of sepsis and septic shock will serve as the examples for this discussion.
No takes yet. Share an insight, caveat, or question.
Bastin et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: